Naloxone

Press Releases

AMA statement on overdose deaths reaching over 100,000 in past year

The AMA again is asking state and federal policymakers to embrace steps that will save lives by ensuring evidence-based treatment and harm reduction to patients.

Advocacy Update

Apr 29, 2022 ·

4 MIN READ

April 29, 2022: State Advocacy Update

AMA supports updates to FSMB telemedicine policy on the latest State Advocacy Update.

Overdose Epidemic

Apr 28, 2022 ·

44 MIN READ

AMA Advocacy Insights webinar series: Drug overdose epidemic

Watch the latest AMA Advocacy Insights webinar on the nation’s drug overdose epidemic—helping children and families, patients with pain.

Overdose Epidemic

Apr 26, 2022 ·

5 MIN READ

Access to treatment is key in addressing drug-overdose epidemic

Learn what’s driving inequities in the drug-overdose epidemic and why giving patients proven treatments is more effective than incarceration.

Accelerating Change in Medical Education

4 MIN READ

Working with health care delivery systems in novel ways

See how consortium schools are partnering with health care systems to bring students out of classrooms so they can learn in authentic health care settings.

Press Releases

AMA welcomes public health approach to overdose epidemic

The AMA urges all health insurers and state legislatures to take steps to make this strategy a reality.

Overdose Epidemic

Apr 7, 2022 ·

15 MIN READ

Shifting the conversation about substance use disorder with Bobby Mukkamala, MD

AMA's Moving Medicine series features physician voices and achievements. Learn more in this discussion with Bobby Mukkamala, MD, on substance use disorder.

Advocacy Update

Apr 1, 2022 ·

4 MIN READ

April 1, 2022: State Advocacy Update

Advocacy tools on physician-led care and more in the latest State Advocacy Update.

Membership Moves Medicine™

Free access to JAMA Network™ and CME
Save hundreds on insurance
Fight for physicians and patient rights

Join the AMA today

Behavioral health integration (BHI) Overcoming Obstacles webinar series

COVID-19 (2019 novel coronavirus) resource center for physicians

AMA STEPS Forward® webinar series: Recorded events

How COVID-19 telemonitoring sets model for other acute conditions

In pandemic’s 3rd year, medical educators also feel strains

Medical education webinars and virtual discussions

May 2022: Kaplan MCAT stumpers put pre-meds to the test

COMLEX Level 1’s move to pass-fail: What it means for DO students

May 13, 2022: Advocacy Update spotlight on prior auth & Medicare Advantage plans

May 13, 2022: National Advocacy Update

Auto & transportation discounts

Give your grad the gift of AMA membership

Business of the June 2022 Meeting of the AMA House of Delegates

2022 Annual Meeting of the HOD: Speakers' updates overview

AMA Constitution & Bylaws

Council on Medical Education reports

Senior Physicians Recognition Month

Women Physicians Section Inspiration Award

AMA leadership and policy development through the World Medical Association

About the Office of International Relations

Naloxone

AMA statement on overdose deaths reaching over 100,000 in past year

April 29, 2022: State Advocacy Update

AMA Advocacy Insights webinar series: Drug overdose epidemic

Access to treatment is key in addressing drug-overdose epidemic

Working with health care delivery systems in novel ways

AMA welcomes public health approach to overdose epidemic

Shifting the conversation about substance use disorder with Bobby Mukkamala, MD

April 1, 2022: State Advocacy Update

Membership Moves Medicine™